Major players profiled in the report include Abbott Diagnostics, Alere Inc., Beckman Coulter, Inc., Cholestech Corp., GE HealthCare, Nanogen Inc., Philips Medical Systems, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., St Jude Medical Inc., among others.
One might dismiss NGEN as a major player, but I would not dismiss their assets at this time.
The above news release, which included Abbott Diagnostics Inc. operates as a subsidiary of Abbott Laboratories at $65.00 a share, and other household names.
More times than not smaller company can stay ahead of the IP curve in which major companies are moving, thus over time making their patents become extremely important down the road.
Just look at what NEOM has now :-)
In micro-caps it's all about what we have, that major players within said industry don't have, and may need one day.
If I see a tightening of Bid/Ask w/volume I'll be a small buyer today.
Fragmenting one piece of data above having more power over the other is not how I think.... lol